Award notice, 8(a) sole source
Relenza, NDC# 00173-0681-22
Relenza
Office of the Assistant Secretary for Administration (Asa), Program Support Center Acq MGMT SVC. Biological Product (except Diagnostic) Manufacturing.
Awarded
GLAXOSMITHKLINE, LLC Durham
$249,900.00 on the award notice, July 23, 2024, contract Relenza
Get the next one like this from Office of the Assistant Secretary for Administration (Asa) by email, the day it is posted.Find my opportunities
This one was awarded in 2024
4 like it are open now in biological product (except diagnostic) manufacturing
- iPSC Culture and Differentiation
National Institutes of Health, National Institutes of Health Olao
PresolicitationNAICS 325414Bethesda, MD75N98027Q00053Closes in 5 daysNov 12 - Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Animal and Plant Health Inspection Service, MRPBS Minneapolis MN
Combined synopsis and solicitationNAICS 325414Anywhere in the US12639527R0001Closes in 3 daysNov 10 - Injectable Egg-Free Influenza Vaccine 2027
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325414Anywhere in the USSPE2DP26R0004Closes in 26 daysDec 3
All 4 open in biological product (except diagnostic) manufacturing
Description
As published on SAM.gov.
'Relenza', Zanamivir inhalant powder, 5mg, 20s, NDC# 00173-0681-22, quantity 9,520 packages.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 16, 2024
Award notice
Awarded to GLAXOSMITHKLINE, LLC Durham for $249,900. SAM.gov, notice df692f0cf01e48cb939598b378541e24
Points of contact
- Tim BouchelleTimothy.Bouchelle@hhs.gov4439476039